News

A post-hoc analysis of the XIRIUS and XOLARIS trials suggest the gene therapy improved some visual function for patients with XLRP, but the reported SAEs require further safety assessments.

More than 98,000 medical device reports have been sent to the FDA since April 2021 regarding Philips Respironics Ventilators, BiPAP, and CPAP machines associated with the PE-PUR foam breakdown.

Based on the findings, investigators suggest the evaluation of diastolic blood pressure be considered as a therapeutic measure in patients with glaucoma.

Despite multi-stakeholder information campaigns supporting the use of biosimilars, barriers remain that hinder uptake.

PET scanning, in particular, has provided advancement in the diagnosis process, which has offered a new perspective on cardiac sarcoidosis for clinicians.

Cooke joins the first episode of 2023 to discuss his colleague’s specific role in lung cancer screening and intervention and advances to minimally invasive, robotic and bronchoscopic techniques.

New research into patient-focused deprescribing strategies for those dealing with the effects of polypharmacy in hospital and post-acute care facilities.

Sofosbuvir-based regimens were the most commonly prescribed therapies to treat hepatitis C virus in Asia, Africa, and the Commonwealth of Independent States.

New research was conducted regarding air pollution and other elements affecting asthma cases in urbanized settings.

A phase 2 trial published in NEJM describes the effects of the oral selective kappa opioid receptor agonist difelikefalin in patients with notalgia paresthetica—a condition with no FDA-approved therapies.

According to the results, 42.8% of participants failed to agree that relevant legislature is in place for the sickle cell disease population, as it doesn't facilitate optimal access to high-quality healthcare.

An analysis of Denmark's FORSYN study suggests new advances in the treatment of chorioretinal vascular diseases have significantly reduced vision loss.

Announced on February 7, the US FDA notification is aimed at alerting consumers around presence of sildenafil and tadalafil in PrimeZen Black 6000, which the agency purports could pose a significant risk for people using nitrates for other chronic conditions, such as diabetes and cardiovascular disease.

Patients with with depression and AHI ≥ 30 show the greatest risk of all-cause mortality.

Data indicate 2 out of 5 patients utilized LVR services among those who received a referral recommendation during the CDSS active phase, while onsite LVR service provision increased utilization rates.

We all want to provide quality care for our patients, but how can you be sure that you are providing it? There are a number of indicators associated with quality care in rheumatoid arthritis. Take this quiz to see how many you can identify.

Kim Zuber, PA-C, and Jane Davis, DNP, provide perspective on guideline recommendations for the management of hepatitis C in people with chronic kidney disease from the Kidney Disease Improving Global Outcomes.

New research into the use of ustekinumab compared to other treatments for psoriasis sheds light on risk for outpatient infections.

The connection between different ADHD subtypes and mood disorders has not been fully explored.

Further adding to the discussion surrounding the impact of endocrine-disrupting chemicals, an analysis of data from the SWAN Multipollutant Study suggests increased exposure to phthlates was linked to a 30-63% increase in risk of developing diabetes among White women in midlife.

New research into the nursing home CMS rating system suggests that a revision may improve the public’s information access.

Latino-English preferred patients had an overall lower rate of screening compared to both non-Hispanic whites and Latino-Spanish preferred patients.

The positivity rate of rhinoviruses and enteroviruses decreased briefly following the onset of the COVID-19 pandemic, but by fall of 2020 resumed almost to pre-pandemic levels.

New 6-month findings from a First-in-Human glaucoma treatment trial indicate the drug delivery platform continued to show a 45% reduction in mean intraocular pressure.

Aflibercept treatment resulted in statistically significant anatomic improvement, but no improvement in visual acuity among patients with NPDR without CI-DME at 4 years of analysis.

The results also show a decrease in antibiotic use, hospital length of stay, and overall cost to the patient.

New research was found on alcohol consumption as a modifiable risk factor in dementia, in a study out of South Korea.

The treatment is a novel, investigational anti-C5 recycling monoclonal antibody showing promise for treating patients with paroxysmal nocturnal hemoglobinuria.